Immunovant, Inc. Common Stock IMVT
Key Stats
- Today's Range
- $32.33 – $33.32
- 50-Day Range
- $22.79 – $36.28
- 52-Week Range
- $13.36 – $36.28
- Volume
- 1.59 million shs
- Average Volume
- 2.19 million shs
- Market Cap
- $6.75 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 7.91
- Price / Sales
- —
Short Interest
- Short Interest
- 0.15%
- Days to Cover
- 3.34
About Immunovant, Inc. Common Stock
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.